First patients treated with proton therapy in Spain at the Quirónsalud proton therapy center in Madrid

First patients treated with proton therapy in Spain at the Quirónsalud proton therapy center in Madrid

Press releases may be edited for formatting or style | January 17, 2020 European News Rad Oncology Proton Therapy
Louvain-la-Neuve, Belgium, 17 January 2020 - IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, is pleased to announce that the Quirónsalud Proton Therapy Center in Madrid, Spain, began treating patients on its IBA Proteus®ONE* on December 26, 2019. These are the first patients to receive proton beam therapy in Spain.

Quirónsalud has been able to treat its first patients following a 12-month ProteusONE installation period. The IBA compact proton therapy system installed in Madrid includes the latest generation Pencil Beam Scanning (PBS), isocenter volumetric imaging (Cone Beam CT) capabilities, as well as the Philips Ambient Experience.

ProteusONE is IBA’s compact intensity modulated proton therapy (IMPT) solution which, due to its open gantry, enables high patient throughput. It benefits from the latest technologies that have been developed with renowned clinical institutions and allows the treatment of patients with a large number of cancer indications.

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

With this additional center, 34 IBA-equipped proton therapy centers are in operation today – 23 Proteus®PLUS* and 11 ProteusONE.

Olivier Legrain, Chief Executive Officer at IBA,commented: “We are delighted that patients in Spain can now benefit from the most advanced cancer treatment technology. Thanks to our continued ability to install our Proteus®ONE solution in less than 12 months, IBA reinforces its position as the fastest proton therapy provider from contract signature to patient treatment. We look forward to continuing our collaboration with Quirónsalud.”

Marta Cremades, Managing Director at Quirónsalud Proton Therapy Center, added: “We are very pleased to bring this cutting-edge technology available to patients in Spain and to start treating the first patients in Spain using proton therapy and Thanks to this technology, we can destroy the cancer cells while limiting the exposure of healthy tissues surrounding the tumor and reducing the risk of secondary cancers. We look forward to collaborating further with our network of hospitals so that all patients who could benefit from proton therapy can access it.”


About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,400 people worldwide, IBA has installed systems across the world.

You Must Be Logged In To Post A Comment